Literature DB >> 7717869

A morphological analysis of the short-term effects of benzene on the development of the hematological cells in the bone marrow of mice and the effects of interleukin-1 alpha on the process.

R Niculescu1, G F Kalf.   

Abstract

Chronic exposure of humans to benzene (BZ), a widely used industrial chemical and a ubiquitous environmental pollutant, causes aplastic anemia and acute myeloid leukemia. The purpose of the studies reported here was to determine whether the observed depression of bone marrow (BM) cellularity in mice administered benzene was reflected in a suppression of development of all of the hematopoietic lineages and to confirm the ability of interleukin-1 alpha (IL-1 alpha) to prevent BZ-induced BM cell depression. We report that BZ, administered twice per day for 2 days to C57B1/6J mice at a dose of 600 mg/kg body weight, caused a significant depression of the total number of nucleated BM cells per femur when measured on day 3. The observed depression reflects a complex situation that represents the net effect of a decrease in the total number of cells of the lymphocytic and erythroid lineages, along with an increase in the number of intermediate and terminally differentiated cells of the granulocytic lineage. An experiment to monitor the effects of BZ over a 7-day period showed a progressive depressive effect on the lymphocytes and an initial depression of the erythroid cells at day 3 that remained constant until day 7. Conversely, the numbers of intermediate and terminally differentiated granulocytes progressively increased over the 7 days. The BM appeared to recover from the depressive effects of BZ immediately upon cessation of exposure, as the number of nucleated BM cells began to rise by day 5 and was equal to that of the control group by day 7. The results expand our earlier finding (Renz and Kalf 1991) that the overall depression of BM cellularity occurs because of an inability of the stromal fibroblast to produce colony-stimulating factors essential for stem and progenitor cell survival. This results from inhibition by the BZ metabolite, hydroquinone (HQ), of the processing of pre-IL-1 alpha to the mature cytokine.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7717869     DOI: 10.1007/s002040050150

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  35 in total

Review 1.  Interleukin-1: biology, pathophysiology, and clinical prospects.

Authors:  L C Platanias; N J Vogelzang
Journal:  Am J Med       Date:  1990-11       Impact factor: 4.965

2.  Short term benzene exposure provides a growth advantage for granulopoietic progenitor cells over erythroid progenitor cells.

Authors:  A M Dempster; C A Snyder
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

3.  Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1 alpha.

Authors:  Y Kobayashi; K Yamamoto; T Saido; H Kawasaki; J J Oppenheim; K Matsushima
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

Review 4.  Production of multilineage growth factors by hematopoietic stromal cells: an intercellular regulatory network involving mononuclear phagocytes and interleukin-1.

Authors:  G C Bagby
Journal:  Blood Cells       Date:  1987

5.  Metabolic activation of hydroquinone by macrophage peroxidase.

Authors:  M J Schlosser; G F Kalf
Journal:  Chem Biol Interact       Date:  1989       Impact factor: 5.192

6.  Interleukin 1 is a radioprotector.

Authors:  R Neta; S Douches; J J Oppenheim
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

7.  Malignancies due to occupational exposure to benzene.

Authors:  M Aksoy
Journal:  Am J Ind Med       Date:  1985       Impact factor: 2.214

8.  The prevention of benzene-induced genotoxicity in mice by indomethacin.

Authors:  S J Pirozzi; J F Renz; G F Kalf
Journal:  Mutat Res       Date:  1989-03       Impact factor: 2.433

9.  Interleukin-1 enhances murine granulopoiesis in vivo.

Authors:  L C Stork; V M Peterson; C H Rundus; W A Robinson
Journal:  Exp Hematol       Date:  1988-02       Impact factor: 3.084

10.  Benzene: epidemiologic observations of leukemia by cell type and adverse health effects associated with low-level exposure.

Authors:  P F Infante; M C White
Journal:  Environ Health Perspect       Date:  1983-10       Impact factor: 9.031

View more
  6 in total

Review 1.  Animal models for acquired bone marrow failure syndromes.

Authors:  Jichun Chen
Journal:  Clin Med Res       Date:  2005-05

Review 2.  Integrated defense system overlaps as a disease model: with examples for multiple chemical sensitivity.

Authors:  S C Rowat
Journal:  Environ Health Perspect       Date:  1998-02       Impact factor: 9.031

3.  Genetic and environmental factors influencing human diseases with telomere dysfunction.

Authors:  Hinh Ly
Journal:  Int J Clin Exp Med       Date:  2009-05-31

4.  The fate of benzene-oxide.

Authors:  Terrence J Monks; Michael Butterworth; Serrine S Lau
Journal:  Chem Biol Interact       Date:  2009-12-29       Impact factor: 5.192

5.  Induction of granulocytic differentiation in a mouse model by benzene and hydroquinone.

Authors:  B A Hazel; A O'Connor; R Niculescu; G F Kalf
Journal:  Environ Health Perspect       Date:  1996-12       Impact factor: 9.031

6.  p-Benzoquinone, a reactive metabolite of benzene, prevents the processing of pre-interleukins-1 alpha and -1 beta to active cytokines by inhibition of the processing enzymes, calpain, and interleukin-1 beta converting enzyme.

Authors:  G F Kalf; J F Renz; R Niculescu
Journal:  Environ Health Perspect       Date:  1996-12       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.